Perrigo Company PLC, like other OTC drug manufacturers, was stung in the first quarter compared to booming sales in early 2020 driven by coronavirus pandemic-driven consumer stockpiling. Unlike its competitors making and marketing their own brands, it can cushion the impact of a slow quarter by announcing another agreement to make more consumer health products marketed under other firms’ brands.
Along with its first-quarter results on 11 May, Perrigo announced it has licensed the Burt’s Bees brand to make and...







